NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 46 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 3.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,000 | -97.0% | 38,143 | -88.6% | 0.00% | -100.0% |
| Q3 2019 | $666,000 | -3.8% | 333,364 | +17.1% | 0.00% | 0.0% |
| Q2 2019 | $692,000 | +220.4% | 284,576 | +221.9% | 0.00% | – |
| Q1 2019 | $216,000 | +22.7% | 88,411 | -26.7% | 0.00% | – |
| Q4 2018 | $176,000 | -47.1% | 120,573 | -2.2% | 0.00% | – |
| Q3 2018 | $333,000 | -92.0% | 123,284 | -85.0% | 0.00% | -100.0% |
| Q1 2018 | $4,140,000 | -20.2% | 823,001 | -5.1% | 0.01% | -14.3% |
| Q4 2017 | $5,188,000 | +579.1% | 867,613 | +1089.8% | 0.01% | +600.0% |
| Q2 2017 | $764,000 | – | 72,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,074,190 | $33,368,000 | 6.74% |
| Novo Holdings A/S | 2,903,800 | $23,782,000 | 3.10% |
| PURA VIDA INVESTMENTS, LLC | 425,000 | $3,481,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $3,276,000 | 0.59% |
| Monashee Investment Management LLC | 188,000 | $1,540,000 | 0.58% |
| Orbimed Advisors | 3,919,600 | $32,102,000 | 0.31% |
| FT Options LLC | 20,000 | $164,000 | 0.25% |
| Rock Springs Capital Management LP | 625,000 | $5,119,000 | 0.24% |
| Rubric Capital Management LP | 300,000 | $2,457,000 | 0.22% |
| Ghost Tree Capital, LLC | 120,000 | $983,000 | 0.21% |